A.G.B. Templeton

939 total citations
29 papers, 725 citations indexed

About

A.G.B. Templeton is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, A.G.B. Templeton has authored 29 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in A.G.B. Templeton's work include Nitric Oxide and Endothelin Effects (7 papers), Pregnancy and preeclampsia studies (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). A.G.B. Templeton is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Pregnancy and preeclampsia studies (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). A.G.B. Templeton collaborates with scholars based in United Kingdom, Czechia and United States. A.G.B. Templeton's co-authors include J.C. McGrath, Margaret R. MacLean, Martin Whittle, Ian Morecroft, V.G. Wilson, John E. Morley, Leslie Patmore, Edwin R. Chilvers, Ian Dainty and Michael Spedding and has published in prestigious journals such as Journal of Virology, Annals of the New York Academy of Sciences and British Journal of Pharmacology.

In The Last Decade

A.G.B. Templeton

29 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.G.B. Templeton United Kingdom 16 319 202 195 186 86 29 725
M. Helen Maguire United States 20 117 0.4× 361 1.8× 124 0.6× 64 0.3× 70 0.8× 58 1.0k
Jacob Rune Jørgensen Denmark 8 64 0.2× 188 0.9× 212 1.1× 70 0.4× 65 0.8× 13 591
E Pastoriza-Muñoz United States 12 109 0.3× 368 1.8× 119 0.6× 97 0.5× 43 0.5× 20 960
Richard A. Borman United Kingdom 8 63 0.2× 223 1.1× 128 0.7× 45 0.2× 55 0.6× 12 1.4k
Takashi Tomita Japan 13 102 0.3× 244 1.2× 71 0.4× 49 0.3× 94 1.1× 42 655
Soo Kyung Kim South Korea 16 233 0.7× 302 1.5× 170 0.9× 17 0.1× 41 0.5× 51 1.2k
J. F. Hansen Denmark 18 78 0.2× 485 2.4× 505 2.6× 61 0.3× 16 0.2× 35 1.3k
Rhys Jones United Kingdom 16 149 0.5× 128 0.6× 69 0.4× 225 1.2× 29 0.3× 34 744
Natalia Borg Sweden 11 35 0.1× 146 0.7× 85 0.4× 25 0.1× 55 0.6× 22 733
Katharine J. Palmer New Zealand 8 133 0.4× 200 1.0× 58 0.3× 22 0.1× 65 0.8× 14 829

Countries citing papers authored by A.G.B. Templeton

Since Specialization
Citations

This map shows the geographic impact of A.G.B. Templeton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G.B. Templeton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G.B. Templeton more than expected).

Fields of papers citing papers by A.G.B. Templeton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.G.B. Templeton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G.B. Templeton. The network helps show where A.G.B. Templeton may publish in the future.

Co-authorship network of co-authors of A.G.B. Templeton

This figure shows the co-authorship network connecting the top 25 collaborators of A.G.B. Templeton. A scholar is included among the top collaborators of A.G.B. Templeton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.G.B. Templeton. A.G.B. Templeton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fahy, William A., Anthony Cahn, A.G.B. Templeton, et al.. (2021). Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study. International Journal of COPD. Volume 16. 1637–1646. 12 indexed citations
2.
Templeton, A.G.B., et al.. (2007). LEFT VENTRICULAR PRESSURE MEASUREMENT IN CONSCIOUS DOGS. Journal of Pharmacological and Toxicological Methods. 56(2). e67–e67. 1 indexed citations
3.
Harris, David T., A.G.B. Templeton, Ross McD. Young, et al.. (2005). Respiratory function in rats restrained for extended periods: Assessment of the effects of bethanecol. Journal of Pharmacological and Toxicological Methods. 52(1). 83–89. 11 indexed citations
4.
Herron, William J., Catherine E. Towers, & A.G.B. Templeton. (2004). Experiences in method development for the analysis of in vitro study solutions for content. Journal of Pharmacological and Toxicological Methods. 49(3). 211–216. 7 indexed citations
5.
Smith, Blair H., Anthony Scott, Wendy Graham, et al.. (2001). A randomized controlled trial of direct access for laparoscopic sterilization. Family Practice. 18(1). 1–8. 8 indexed citations
6.
Patmore, Leslie, et al.. (2000). Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration. European Journal of Pharmacology. 406(3). 449–452. 49 indexed citations
7.
Templeton, A.G.B., et al.. (1998). Effects of S-salbutamol on Human Isolated Bronchus. Pulmonary Pharmacology & Therapeutics. 11(1). 1–6. 63 indexed citations
8.
MacLean, Margaret R., et al.. (1996). Evidence for 5‐HT1‐like receptor‐mediated vasoconstriction in human pulmonary artery. British Journal of Pharmacology. 119(2). 277–282. 76 indexed citations
9.
McGrath, J.C., Christine M. Brown, C.J. Daly, et al.. (1995). The Relationship between the Adrenoceptor and Nonadrenoceptor‐Mediated Effects of Imidazoline‐ and Imidazole‐Containing Compoundsfn1. Annals of the New York Academy of Sciences. 763(1). 591–605. 6 indexed citations
10.
MacLean, Margaret R., et al.. (1994). 5-HT1-Receptor-mediated Vasoconstriction in Bovine Isolated Pulmonary Arteries: Influences of Vascular Endothelium and Tone. Pulmonary Pharmacology. 7(1). 65–72. 43 indexed citations
11.
12.
Templeton, A.G.B., John‏ Kingdom, Martin Whittle, & J.C. McGrath. (1993). Contractile responses of the human umbilical artery from pregnancies complicated by intrauterine growth retardation. Placenta. 14(5). 563–570. 4 indexed citations
13.
Templeton, A.G.B., et al.. (1993). Thromboxane A2 analogue, U-46619, potentiates calcium-activated force in human umbilical artery. American Journal of Physiology-Heart and Circulatory Physiology. 264(6). H1878–H1883. 19 indexed citations
14.
MacLean, Margaret R., A.G.B. Templeton, & J.C. McGrath. (1992). The influence of endothelin‐1 on human foeto‐placental blood vessels: a comparison with 5‐hydroxytryptamine. British Journal of Pharmacology. 106(4). 937–941. 35 indexed citations
15.
Templeton, A.G.B., J.C. McGrath, & Martin Whittle. (1991). The role of endogenous thromboxane in contractions to U46619, oxygen, 5‐HT and 5‐CT in the human isolated umbilical artery. British Journal of Pharmacology. 103(1). 1079–1084. 41 indexed citations
16.
McGrath, J.C., William Dunn, & A.G.B. Templeton. (1990). Physiological Modulation of α-Adrenoceptor and 5HT Receptor Expression in Blood Vessels. Journal of Vascular Research. 27(2-5). 146–152. 8 indexed citations
17.
Dainty, Ian, J.C. McGrath, Michael Spedding, & A.G.B. Templeton. (1990). The influence of the initial stretch and the agonist‐induced tone on the effect of basal and stimulated release of EDRF. British Journal of Pharmacology. 100(4). 767–773. 48 indexed citations
18.
19.
McQueen, James, Alan G. Jardine, John‏ Kingdom, et al.. (1990). Interaction of Angiotensin II and Atrial Natriuretic Peptide in the Human Fetoplacental Unit. American Journal of Hypertension. 3(8_Pt_1). 641–644. 27 indexed citations
20.
Templeton, A.G.B., et al.. (1989). Evidence for prazosin‐resistant, rauwolscine‐sensitive α‐adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. British Journal of Pharmacology. 97(2). 563–571. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Helen Maguire Breakdown of academic impact, for papers by Jacob Rune Jørgensen Breakdown of academic impact, for papers by E Pastoriza-Muñoz Breakdown of academic impact, for papers by Richard A. Borman Breakdown of academic impact, for papers by Takashi Tomita Breakdown of academic impact, for papers by Soo Kyung Kim Breakdown of academic impact, for papers by J. F. Hansen Breakdown of academic impact, for papers by Rhys Jones Breakdown of academic impact, for papers by Natalia Borg Breakdown of academic impact, for papers by Katharine J. Palmer
Rankless by CCL
2026